Zhong-Qiu Liu Selected Research

Fatty Acids (Saturated Fatty Acids)

1/2021

Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhong-Qiu Liu Research Topics

Disease

9	Neoplasms (Cancer) 07/2022 - 01/2015
5	Inflammation (Inflammations) 01/2022 - 10/2017
4	Arthritis (Polyarthritis) 08/2022 - 10/2017
4	Rheumatoid Arthritis 08/2022 - 10/2014
4	Breast Neoplasms (Breast Cancer) 07/2022 - 04/2014
2	Edema (Dropsy) 01/2022 - 10/2017
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 02/2016
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 01/2015
1	Vomiting 01/2022
1	Poisoning 01/2022
1	Disease Progression 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Atherosclerosis 01/2020
1	Rheumatic Diseases (Rheumatism) 05/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Carcinogenesis 01/2018

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 05/2018 - 04/2014
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2022 - 05/2018
3	Pharmaceutical PreparationsIBA 07/2022 - 01/2015
3	AlkaloidsIBA 01/2022 - 01/2018
3	Dinoprostone (PGE2)FDA Link 01/2022 - 01/2018
2	farnesylthiosalicylic acidIBA 07/2022 - 01/2017
2	Coloring Agents (Dyes)IBA 07/2022 - 01/2017
2	Prostaglandin-E SynthasesIBA 01/2022 - 10/2017
2	Silybin (Lagosa)IBA 01/2021 - 01/2018
2	EnzymesIBA 01/2021 - 01/2017
2	Multidrug Resistance-Associated Protein 2IBA 05/2018 - 05/2018
2	Protein Isoforms (Isoforms)IBA 02/2016 - 01/2015
1	Antirheumatic Agents (DMARD)IBA 08/2022
1	GlucosidesIBA 08/2022
1	Methotrexate (Mexate)FDA LinkGeneric 08/2022
1	nobiletinIBA 08/2022
1	Peptides (Polypeptides)IBA 07/2022
1	AnionsIBA 07/2022
1	yunaconitineIBA 01/2022
1	crassicauline AIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2022
1	Fatty Acid-Binding ProteinsIBA 01/2021
1	CytokinesIBA 01/2021
1	CholesterolIBA 01/2021
1	Cholesterol 7-alpha-Hydroxylase (Cholesterol 7 alpha Hydroxylase)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2021
1	LipidsIBA 01/2021
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	AlkB EnzymesIBA 11/2020
1	Protons (Proton)IBA 01/2020
1	MethyltransferasesIBA 01/2018
1	LipopolysaccharidesIBA 01/2018
1	evodiamineIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	A-Form DNA (A-DNA)IBA 01/2018
1	SilymarinIBA 01/2018
1	Urethane (Ethyl Carbamate)IBA 01/2018
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2017
1	sinomenineIBA 10/2017
1	CollagenIBA 10/2017
1	CarrageenanIBA 10/2017
1	SulfotransferasesIBA 01/2017
1	honokiolIBA 01/2017
1	3-methyladenineIBA 01/2017
1	monoamine-sulfating phenol sulfotransferaseIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	heptamethine cyanine dyeIBA 01/2017
1	Sirtuin 3IBA 01/2017
1	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2016
1	Methionine (L-Methionine)FDA Link 02/2016
1	Tyrosine Kinase InhibitorsIBA 02/2016
1	ErbB Receptors (EGF Receptor)IBA 02/2016
1	sanguinarineIBA 02/2016
1	FlavonoidsIBA 01/2016
1	tangeretinIBA 01/2016
1	Uridine Diphosphate (UDP)IBA 01/2015
1	Therapeutic UsesIBA 10/2014
1	UDP-Glucuronosyltransferase 1A9IBA 04/2014
1	GlucuronidesIBA 04/2014
1	LuteolinIBA 04/2014

Therapy/Procedure

3	Therapeutics 07/2022 - 01/2019